Hoth Therapeutics, Inc.
HOTH
$1.20
$0.065.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 110.98% | -23.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 85.52% | -36.72% | |||
| Operating Income | -85.52% | 36.72% | |||
| Income Before Tax | -86.67% | 36.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -86.67% | 36.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -86.67% | 36.72% | |||
| EBIT | -85.52% | 36.72% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -78.43% | 38.89% | |||
| Normalized Basic EPS | -77.37% | 38.90% | |||
| EPS Diluted | -78.43% | 38.89% | |||
| Normalized Diluted EPS | -77.37% | 38.90% | |||
| Average Basic Shares Outstanding | 4.61% | 3.56% | |||
| Average Diluted Shares Outstanding | 4.61% | 3.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||